Sylvania Platinum (SLP) Competitors

Dr. Martens (LON:DOCS) and Sylvania Platinum (LON:SLP) are both small-cap consumer cyclical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Do institutionals & insiders have more ownership in DOCS or SLP?

69.5% of Dr. Martens shares are held by institutional investors. Comparatively, 17.8% of Sylvania Platinum shares are held by institutional investors. 4.4% of Dr. Martens shares are held by company insiders. Comparatively, 12.2% of Sylvania Platinum shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Is DOCS or SLP a better dividend stock?

Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 5.8%. Sylvania Platinum pays an annual dividend of GBX 2 per share and has a dividend yield of 3.5%. Dr. Martens pays out 42.5% of its earnings in the form of a dividend. Sylvania Platinum pays out 93.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Dr. Martens is clearly the better dividend stock, given its higher yield and lower payout ratio.

Does the media favor DOCS or SLP?

In the previous week, Dr. Martens had 3 more articles in the media than Sylvania Platinum. MarketBeat recorded 4 mentions for Dr. Martens and 1 mentions for Sylvania Platinum. Dr. Martens' average media sentiment score of 1.21 beat Sylvania Platinum's score of -0.44 indicating that Dr. Martens is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dr. Martens	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sylvania Platinum	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more volatility and risk, DOCS or SLP?

Dr. Martens has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500. Comparatively, Sylvania Platinum has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500.

Does the MarketBeat Community prefer DOCS or SLP?

Sylvania Platinum received 223 more outperform votes than Dr. Martens when rated by MarketBeat users. However, 91.67% of users gave Dr. Martens an outperform vote while only 79.59% of users gave Sylvania Platinum an outperform vote.

Company	Underperform	Outperform
Dr. Martens	Outperform Votes 11 91.67%	Underperform Votes 1 8.33%
Sylvania Platinum	Outperform Votes 234 79.59%	Underperform Votes 60 20.41%

Is DOCS or SLP more profitable?

Sylvania Platinum has a net margin of 8.55% compared to Dr. Martens' net margin of 7.89%. Dr. Martens' return on equity of 18.91% beat Sylvania Platinum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dr. Martens	7.89%	18.91%	8.12%
Sylvania Platinum	8.55%	2.82%	1.69%

Which has stronger earnings and valuation, DOCS or SLP?

Dr. Martens has higher revenue and earnings than Sylvania Platinum. Dr. Martens is trading at a lower price-to-earnings ratio than Sylvania Platinum, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dr. Martens	£874.20M	0.58	£68.97M	£7.05	7.37
Sylvania Platinum	£99.97M	1.85	£8.54M	£2.13	26.83

Summary

Dr. Martens beats Sylvania Platinum on 11 of the 17 factors compared between the two stocks.